pmc logo image
Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?
Graham B Byrnes, Melissa C Southey, John L Hopper
Breast Cancer Res. 2008; 10(3): 208. Published online 2008 June 5. doi: 10.1186/bcr2099
PMCID:
PMC2481495
Abstract Full Text PDF–460K Supplementary Material
 Is Cited by the Following 7 Articles in this Archive:
Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1
Sharon B Cantor, Shawna Guillemette
Future Oncol. Author manuscript; available in PMC 2011 December 1.
Published in final edited form as: Future Oncol. 2011 February; 7(2): 253–261. doi: 10.2217/fon.10.191
PMCID:
PMC3109611
Abstract Full Text PDF–171K
Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study
Florence Le Calvez-Kelm, Fabienne Lesueur, Francesca Damiola, Maxime Vallée, Catherine Voegele, Davit Babikyan, Geoffroy Durand, Nathalie Forey, Sandrine McKay-Chopin, Nivonirina Robinot, Tù Nguyen-Dumont, Alun Thomas, Graham B Byrnes, John L Hopper, Melissa C Southey, Irene L Andrulis, Esther M John, Sean V Tavtigian
Breast Cancer Res. 2011; 13(1): R6. Published online 2011 January 18. doi: 10.1186/bcr2810
PMCID:
PMC3109572
Abstract Full Text PDF–327K Supplementary Material
A PALB2 mutation associated with high risk of breast cancer
Melissa C Southey, Zhi L Teo, James G Dowty, Fabrice A Odefrey, Daniel J Park, Marc Tischkowitz, Nelly Sabbaghian, Carmel Apicella, Graham B Byrnes, Ingrid Winship, Laura Baglietto, Graham G Giles, David E Goldgar, William D Foulkes, John L Hopper, kConFab
Breast Cancer Res. 2010; 12(6): R109. Published online 2010 December 23. doi: 10.1186/bcr2796
PMCID:
PMC3046454
Abstract Full Text PDF–456K Supplementary Material
PALB2/FANCN - recombining cancer and Fanconi anemia
Marc Tischkowitz, Bing Xia
Cancer Res. Author manuscript; available in PMC 2011 October 1.
Published in final edited form as: Cancer Res. 2010 October 1; 70(19): 7353–7359. Published online 2010 September 21. doi: 10.1158/0008-5472.CAN-10-1012
PMCID:
PMC2948578
Abstract Full Text PDF–643K
Population-Based Estimate of the Contribution of TP53 Mutations to Subgroups of Early-Onset Breast Cancer: Australian Breast Cancer Family Study
Judy Mouchawar, Christopher Korch, Tim Byers, Todd M. Pitts, Efang Li, Margaret R.E. McCredie, Graham G. Giles, John L. Hopper, Melissa C. Southey
Cancer Res. Author manuscript; available in PMC 2011 December 1.
Published in final edited form as: Cancer Res. 2010 June 15; 70(12): 4795–4800. Published online 2010 May 25. doi: 10.1158/0008-5472.CAN-09-0851
PMCID:
PMC3228832
Abstract Full Text PDF–293K
Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband
J Gronwald, C Cybulski, W Piesiak, J Suchy, T Huzarski, T Byrski, B Gorski, T Debniak, M Szwiec, D Wokolowczyk, M Matuszewski, P Sun, J Lubinski, S A Narod
Br J Cancer. 2009 May 5; 100(9): 1508–1512. Published online 2009 April 28. doi: 10.1038/sj.bjc.6605038
PMCID:
PMC2694428
Abstract Full Text PDF–108K
Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1,828 Bilateral Breast Cancers and 7,030 Controls
Olivia Fletcher, Nichola Johnson, Isabel dos Santos Silva, Outi Kilpivaara, Kristiina Aittomäki, Carl Blomqvist, Heli Nevanlinna, Marijke Wasielewski, Hanne Meijers-Heijerboer, Annegien Broeks, Marjanka K. Schmidt, Laura J. Van’t Veer, Michael Bremer, Thilo Dörk, Elena V. Chekmariova, Anna P. Sokolenko, Evgeny N. Imyanitov, Ute Hamann, Muhammad U. Rashid, Hiltrud Brauch, Christina Justenhoven, Alan Ashworth, Julian Peto
Cancer Epidemiol Biomarkers Prev. Author manuscript; available in PMC 2009 August 17.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 January; 18(1): 230–234. doi: 10.1158/1055-9965.EPI-08-0416
PMCID:
PMC2727696
Abstract Full Text PDF–370K Supplementary Material
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk